HQL (abrdn Life Sciences Investors) EV-to-FCF : (As of Dec. 11, 2024)

abrdn Life Sciences Investors EV-to-FCF Chart

abrdn Life Sciences Investors Semi-Annual Data
	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
EV-to-FCF	Get a 7-Day Free Trial										-	-	-	-	-

Competitive Comparison of abrdn Life Sciences Investors's EV-to-FCF

For the Asset Management subindustry, abrdn Life Sciences Investors's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

abrdn Life Sciences Investors's EV-to-FCF Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, abrdn Life Sciences Investors's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where abrdn Life Sciences Investors's EV-to-FCF falls into.

abrdn Life Sciences Investors EV-to-FCF Calculation

abrdn Life Sciences Investors's EV-to-FCF for today is calculated as:

abrdn Life Sciences Investors's current Enterprise Value is $388.10 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. abrdn Life Sciences Investors's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

abrdn Life Sciences Investors  (NYSE:HQL) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

abrdn Life Sciences Investors's PE Ratio (TTM) for today is calculated as:

abrdn Life Sciences Investors's share price for today is $14.19.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. abrdn Life Sciences Investors's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $3.040.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

abrdn Life Sciences Investors EV-to-FCF Related Terms

Thank you for viewing the detailed overview of abrdn Life Sciences Investors's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

abrdn Life Sciences Investors Business Description